Allogene Therapeutics (NASDAQ:ALLO) Stock Rating Lowered by Citizens Jmp
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) was downgraded by research analysts at Citizens Jmp from an “outperform” rating to a “market perform” rating in a research note issued on Wednesday, Marketbeat reports. A number of other brokerages have also recently commented on ALLO. Canaccord Genuity Group reissued a “buy” rating and issued a $14.00 […]
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) was downgraded by research analysts at Citizens Jmp from an “outperform” rating to a “market perform” rating in a research note issued on Wednesday, Marketbeat reports. A number of other brokerages have also recently commented on ALLO. Canaccord Genuity Group reissued a “buy” rating and issued a $14.00 […]
